A jury awarded Retractable Technologies Inc. more than $113 million after it determined a competitor attempted to obtain a monopoly in the plastic safety syringe market. Retractable Technologies sued ...

VanishPoint® syringe sales have historically comprised most of our sales. VanishPoint® syringe sales were 89.9%, 84.9%, and 85.6% of our revenues in 2017, 2018, and 2019. As we have previously ...

Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV catheter products are designed ...

Retractable Technologies (NYSE:RVP) its VanishPoint safety syringes are not part of a safety advisory issued by the FDA on Thursday about suspected performance problems with certain syringes ...

A federal judge has ordered Becton Dickinson & Co. to pay $340 million to Retractable Technologies, Inc. (RVP) in a long-running dispute over the smaller company's allegations of false advertising. In ...

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2018. Further details concerning the ...

agkorce Nigeria Limited has launched the MK VanishPoint Retractable Syringes and Needles. These modern medical apparatus were being introduced into Africa’s largest economic for the first time. The MK ...

Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $10.1 million for the third quarter of 2025 and an operating loss of $3.7 million for the period, as compared to total ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more.

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2019. Further details concerning the ...